date:Jun 13, 2014
b reduced GI in all seven applications - by 8% to 20%. The percentage of GI reduction was shown to be dose-dependent and directly proportional to the amount of Benecarb added as a percentage of available carbohydrate. Equally as important, it was also shown that Benecarb reduced postprandial glucose and insulin response.
According to Dr. Barbara Davis, Director, Medical Scientific Affairs at PLT Health Solutions, these studies can support food and beverage claims that will resonate with consum